Sells products across four main business groups and an 'Others' category, generating FY26 revenue of ₹5,089.76 crore. Transportation & Electronics was the largest segment at ₹1,845.54 crore (36.3% of segment revenue) with segment EBIT of ₹347.79 crore, followed by Safety & Industrial at ₹1,640.04 crore (32.2%, EBIT ₹257.57 crore) and Health Care at ₹1,016.58 crore (20.0%, EBIT ₹209.82 crore). Consumer contributed ₹537.24 crore (10.6%, EBIT ₹94.11 crore), with Others adding ₹50.36 crore (1.0%). The business runs three manufacturing plants, one R&D centre, and two customer technical centres, and reported about 1,273 employees as of FY26. Materials were the largest cost line at 35.2% of revenue, ahead of other operating expenses (13.5%) and employee costs (9.5%). In July 2026, the company temporarily halted manufacturing at its Ahmedabad plant due to flooding, while other plants had capacity to cover; separately in June 2026, the board approved selling a non-operational land parcel of about 4.13 acres with 8,001 sq meters of built-up area in Pimpri, Pune for ₹82 crore. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Transportation & Electronics (36%), Safety & Industrial (32%), Health Care (20%), Consumer (11%), Others (1%). Diversified manufacturer and marketer across industrial, safety, healthcare, and consumer segments
| ₹ crore · consolidated | FY20 | FY21 | FY22 | FY23 | FY24 |
|---|---|---|---|---|---|
| Revenue | 2,987 | 2,605 | 3,336 | 3,959 | 4,189 |
| EBITDA (ex other income) | 450 | 259 | 389 | 604 | 759 |
| margin % | 15.1 | 10.0 | 11.7 | 15.3 | 18.1 |
| Owners' profit | 0 | 0 | 0 | 451 | 0 |
| EPS, as reported (₹) | 285.99 | 144.14 | 241.43 | 400.37 | 517.90 |
| ROE % · ROCE % | 18.4 · 24.2 | 8.5 · 11.3 | 12.5 · 16.5 | 26.9 · 35.4 | 27.2 · 35.8 |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from operations | — | 321 | 327 | 465 | 643 |
| Capex | — | (42) | (70) | (60) | 0 |
| ₹ crore | Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 977 | 993 | 1,046 | 1,050 | 1,040 | 1,006 | 1,095 | 1,047 |
| Profit before tax | 143 | 167 | 184 | 173 | 196 | 181 | 231 | 211 |
| Net profit | 106 | 125 | 136 | 129 | 146 | 135 | 173 | 157 |
| EPS (₹) | 94.30 | 110.79 | 120.48 | 114.70 | 129.71 | 120.05 | 153.44 | 139.50 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Consumer | 428 | 10.2 |
| Health Care | 761 | 18.2 |
| Others | 18 | 0.4 |
| Safety & Industrial | 1,333 | 31.8 |
| Transportation & Electronics | 1,649 | 39.4 |
| Total, before eliminations | 4,189 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| GODREJ INDUSTRIES LTD |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 28 Aug 2026 · Clarification on volume movement - no undisclosed info | compliance | low | — | — |
| 28 Aug 2026 · BSE seeks clarification on 3M India volume movement | regulatory legal | medium | — | — |
| 27 Aug 2026 · 3M India 39th AGM: All 7 resolutions passed with strong majority | board shareholder meetings | low | — | — |
| 26 Aug 2026 · 3M India 39th AGM: Rs 506 dividend, 14.5 percent revenue growth | board shareholder meetings | medium | — | — |
| 26 Aug 2026 · 3M India 39th AGM: Revenue up 14.5 percent, Rs 506 dividend recommended | board shareholder meetings | medium | — | — |
| 14 Aug 2026 · 3M India Q1 FY26-27: Revenue up 19%, PAT up 31% boosted by land sale gain | results | high | — | — |
| 14 Aug 2026 · 3M India Q1 FY27 PAT up 31% on land sale gain, revenue grows 19% | results | high | — | — |
| 11 Aug 2026 · 3M India Ahmedabad plant fully resumes operations after flood disruption | capex operations | high | — | — |
| 5 Aug 2026 · 39th AGM notice and remote e-voting info | compliance | minimal | — | — |
| 4 Aug 2026 · 3M India 39th AGM notice and Annual Report FY 25-26 filed | results | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| 38,055 |
| 32.4 |
| 1.64 |
| 14.5 |
| 10.4 |
| 6.4 |
| 19.0 |
| 27.3 |
| 3M INDIA LIMITED ◆ | 36,735 | 60.1 | 17.11 | 42.6 | 27.2 | 35.7 | 6.8 | 21.7 |
| DCM SHRIRAM LIMITED | 15,675 | 10.8 | 2.03 | 10.9 | 11.1 | 9.5 | 11.4 | 11.7 |
| KAMA HOLDINGS LTD. | 7,275 | 7.8 | 0.48 | 1.9 | 12.3 | — | 13.5 | 22.4 |
| BALMER LAWRIE & CO LTD | 2,883 | 10.3 | 1.38 | 7.4 | 13.0 | 11.2 | 12.2 | 14.8 |
| TTK HEALTHCARE LIMITED | 1,576 | 21.3 | 1.41 | — | 5.9 | 7.4 | — | 12.2 |
| EMPIRE INDUSTRIES LTD. | 634 | 12.3 | 1.80 | — | 14.7 | 10.5 | — | 19.5 |
| GILLANDERS ARBUTHNOT LTD | 223 | 12.8 | 0.86 | 10.5 | 3.7 | 3.5 | 0.0 | 9.0 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 60.1 | 12.3 | 14 of 15 | 7% |
| P/B | 17.1 | 1.2 | 14 of 14 | 0% |
| ROCE | 35.7 | 8.4 | 1 of 14 | 100% |
| ROE | 27.2 | 10.7 | 2 of 14 | 92% |
| Debt / Equity | 0.0 | 0.3 | 1 of 14 | 92% |
| EBITDA margin | 21.7 | 20.6 | 7 of 14 | 54% |
| Revenue growth | (0.3) | 11.9 | 14 of 14 | 0% |
| Profit growth | 21.6 | 100.4 | 10 of 13 | 25% |
| Market cap | 36735 | 223 | 2 of 15 | 93% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
